1429024-45-2

Basic information

• Product Name: (3-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)phenyl)(phenyl)methanone
• Synonyms: (3-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)phenyl)(phenyl)methanone
• CAS NO: 1429024-45-2
• Molecular Weight: 350.764
• Mol File: 1429024-45-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)phenyl)(phenyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (3-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)phenyl)(phenyl)methanone(1429024-45-2)
• EPA Substance Registry System: (3-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)phenyl)(phenyl)methanone(1429024-45-2)

Safety Data

• Hazardous Substances Data: 1429024-45-2(Hazardous Substances Data)

Upstream product

• 33050-32-7 6-chloro-1,2,4-triazolo[4,3-b]pyridazin-3(2H)-one 
• 33050-38-3 3,6-dichloro-1,2,4-triazolo<4,3-b>pyridazine 
• 13020-57-0 3-hydroxybenzophenone 

Relevant articles and documents

DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS

The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.